239 related articles for article (PubMed ID: 28299760)
81. Endometrial stromal sarcoma of the uterus. A clinical and histopathological study. The Radiumhemmet series 1936-1981.
Larson B; Silfverswärd C; Nilsson B; Pettersson F
Eur J Obstet Gynecol Reprod Biol; 1990; 35(2-3):239-49. PubMed ID: 2335259
[TBL] [Abstract][Full Text] [Related]
82. Current Concepts in the Imaging of Uterine Sarcomas.
Petrocelli R; Hindman N; Reinhold C
Radiol Clin North Am; 2023 Jul; 61(4):627-638. PubMed ID: 37169428
[TBL] [Abstract][Full Text] [Related]
83. Treatment of uterine sarcoma. A survey of 49 patients.
Soumarová R; Horová H; Seneklová Z; Ruzicková J; Horová I; Budíková M; Slampa P; Kalábová R
Arch Gynecol Obstet; 2002 Apr; 266(2):92-5. PubMed ID: 12049303
[TBL] [Abstract][Full Text] [Related]
84. Trends in the treatment of uterine leiomyosarcoma in the Medicare population.
Foley OW; Rauh-Hain JA; Clemmer J; Clark RM; Hall T; Diver EJ; Schorge JO; del Carmen MG
Int J Gynecol Cancer; 2015 Mar; 25(3):453-8. PubMed ID: 25628107
[TBL] [Abstract][Full Text] [Related]
85. Evaluation of treatment results and prognostic factors of uterine sarcoma: A single-center experience.
Momtahan M; Emami F; Sari Aslani F; Akbarzadeh-Jahromi M
J Chin Med Assoc; 2020 Jan; 83(1):84-88. PubMed ID: 31517774
[TBL] [Abstract][Full Text] [Related]
86. Treatment of uterine sarcomas.
Echt G; Jepson J; Steel J; Langholz B; Luxton G; Hernandez W; Astrahan M; Petrovich Z
Cancer; 1990 Jul; 66(1):35-9. PubMed ID: 2354406
[TBL] [Abstract][Full Text] [Related]
87. Treatment of endometrial stromal tumors.
Berchuck A; Rubin SC; Hoskins WJ; Saigo PE; Pierce VK; Lewis JL
Gynecol Oncol; 1990 Jan; 36(1):60-5. PubMed ID: 2295453
[TBL] [Abstract][Full Text] [Related]
88. Epidemiological guideline influence on the therapeutic trend and patient outcome of uterine cervical cancer in Japan: Japan society of gynecologic oncology guideline evaluation committee project.
Shigeta S; Shida M; Nagase S; Ikeda M; Takahashi F; Shibata T; Yamagami W; Katabuchi H; Yaegashi N; Aoki D; Mikami M
Gynecol Oncol; 2020 Oct; 159(1):248-255. PubMed ID: 32718728
[TBL] [Abstract][Full Text] [Related]
89. Uterine sarcoma: a report of 57 cases over a 16-year period analysis.
Tsikouras P; Liberis V; Galazios G; Savidis A; Grapsa A; Grapsas X; Teichmann AT; Maroulis G
Eur J Gynaecol Oncol; 2008; 29(2):129-34. PubMed ID: 18459545
[TBL] [Abstract][Full Text] [Related]
90. Endometrioid stromal sarcomas arising from ovarian and extraovarian endometriosis: report of two cases and review of the literature.
Baiocchi G; Kavanagh JJ; Wharton JT
Gynecol Oncol; 1990 Jan; 36(1):147-51. PubMed ID: 2403959
[TBL] [Abstract][Full Text] [Related]
91. Current management of uterine sarcomas.
García-Martínez E; Egea Prefasi L; García-Donas J; Escolar-Pérez PP; Pastor F; González-Martín A
Clin Transl Oncol; 2011 May; 13(5):307-14. PubMed ID: 21596658
[TBL] [Abstract][Full Text] [Related]
92. [Results of treatment on 56 sarcomas of the uterus between 1953 and 1977 (author's transl)].
Kaether M; Franz G; Schmidt U
Pathol Res Pract; 1980 Oct; 169(2):179-84. PubMed ID: 7443575
[TBL] [Abstract][Full Text] [Related]
93. Uterine sarcomas: an analysis of 69 patient.
Mantravadi RV; Bardawil WA; Lochman DJ; Liebner EJ; Townsend DE; Chao JH; Chaudhuri B
Int J Radiat Oncol Biol Phys; 1981 Jul; 7(7):917-22. PubMed ID: 7309589
[No Abstract] [Full Text] [Related]
94. Endometrial stromal sarcoma: a clinicopathologic study of 11 cases with determination of estrogen and progestin receptor levels in three tumors.
Katz L; Merino MJ; Sakamoto H; Schwartz PE
Gynecol Oncol; 1987 Jan; 26(1):87-97. PubMed ID: 3792939
[TBL] [Abstract][Full Text] [Related]
95. Observations on the use of adjuvant radiation therapy in patients with stage I and II uterine sarcoma.
Hornback NB; Omura G; Major FJ
Int J Radiat Oncol Biol Phys; 1986 Dec; 12(12):2127-30. PubMed ID: 3793549
[TBL] [Abstract][Full Text] [Related]
96. Uterine sarcomas: A critical review of the literature.
Giannini A; Golia D'Augè T; Bogani G; Laganà AS; Chiantera V; Vizza E; Muzii L; Di Donato V
Eur J Obstet Gynecol Reprod Biol; 2023 Aug; 287():166-170. PubMed ID: 37348383
[TBL] [Abstract][Full Text] [Related]
97. Uterine sarcoma part III-Targeted therapy: The Taiwan Association of Gynecology (TAG) systematic review.
Yen MS; Chen JR; Wang PH; Wen KC; Chen YJ; Ng HT;
Taiwan J Obstet Gynecol; 2016 Oct; 55(5):625-634. PubMed ID: 27751406
[TBL] [Abstract][Full Text] [Related]
98. Autopsy findings in patients with uterine sarcoma.
Fleming WP; Peters WA; Kumar NB; Morley GW
Gynecol Oncol; 1984 Oct; 19(2):168-72. PubMed ID: 6489828
[TBL] [Abstract][Full Text] [Related]
99. Retrospective study of management of uterine sarcomas at Oxford 1990-1998: role of adjuvant treatment.
Riddle PJ; Echeta CB; Manek S; Lavery BA; Charnock FM; Mackenzie I; Ganesan TS
Clin Oncol (R Coll Radiol); 2002 Feb; 14(1):54-61. PubMed ID: 11899904
[TBL] [Abstract][Full Text] [Related]
100. Characteristics and management of uterine sarcoma patients treated at the Tom Baker Cancer Centre.
Kelly KL; Craighead PS
Int J Gynecol Cancer; 2005; 15(1):132-9. PubMed ID: 15670308
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
